Pt(IV)/Re(I) Chitosan Conjugates as a Flexible Platform for the Transport of Therapeutic and/or Diagnostic Anticancer Agents
New chitosan derivatives modified with (3-carboxypropyl)trimethylammonium chloride (1) and coupled with (OC-6-44)-diammine(4-carboxypropanoato)dichloridoethanolatoplatinum(IV) (2), were synthesized and their preliminary biological evaluation carried out in human tumor cells. Some of these derivative...
Main Authors: | Elisabetta Gabano, Letícia do Quental, Elena Perin, Francisco Silva, Paula Raposinho, António Paulo, Mauro Ravera |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-12-01
|
Series: | Inorganics |
Subjects: | |
Online Access: | https://www.mdpi.com/2304-6740/6/1/4 |
Similar Items
-
Pt(IV) Prodrugs with NSAIDs as Axial Ligands
by: Daniil Spector, et al.
Published: (2021-04-01) -
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen <sup>†</sup>
by: Mauro Ravera, et al.
Published: (2019-06-01) -
Unsymmetric Cisplatin-Based Pt(IV) Conjugates Containing a PARP-1 Inhibitor Pharmacophore Tested on Malignant Pleural Mesothelioma Cell Lines
by: Elisabetta Gabano, et al.
Published: (2021-08-01) -
Pt, Re and Pt–Re incorporation in sulfated zirconia as catalysts for n-pentane isomerization
by: A.K. Aboul-Gheit, et al.
Published: (2014-09-01) -
Photoactivatable Platinum-Based Anticancer Drugs: Mode of Photoactivation and Mechanism of Action
by: Ziwen Dai, et al.
Published: (2020-11-01)